Pipeline
Meinox rolls out four product pipelines, aiming at large, global, and unmet needs. We are focusing our product pipeline on two distinct indications: Cancer (i.e. prostate, pancreas, leukemia) and obesity/diabetes. While these two indications may seem a world apart, excellent targets have been identified in both areas of disease, opening up the possibility to leverage our technology to its full potential.
We are looking for strategic partnerships and VC investment towards in GMP grade API synthesis, pre-formulation and preclinical validations.
We are looking for strategic partnerships and VC investment towards in GMP grade API synthesis, pre-formulation and preclinical validations.